Filter Results
:
(1,502)
Show Results For
-
All HBS Web
(7,227)
- Faculty Publications (1,502)
Show Results For
-
All HBS Web
(7,227)
- Faculty Publications (1,502)
Page 1 of
1,502
Results
→
- May 2024
- Case
HarvEast
By: Jeremy Friedman and Natalie Kindred
In late 2023, Dmitry Skornyakov, CEO of Ukrainian agribusiness HarvEast, was navigating the turmoil caused by Russia’s invasion of Ukraine that began in 2014 and escalated into full-scale war in February 2022. Before the full-scale invasion, HarvEast managed 127,000...
View Details
Keywords:
Plant-Based Agribusiness;
Goods and Commodities;
Natural Resources;
Food;
Problems and Challenges;
Adaptation;
Innovation and Management;
Crisis Management;
Logistics;
Supply Chain;
Risk and Uncertainty;
Loss;
Trust;
Human Needs;
War;
Agriculture and Agribusiness Industry;
Chile;
South America;
Latin America
- 2024
- Working Paper
Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency
By: Mosab Hammoudeh, Joshua Lev Krieger and Jiajie Xu
This paper investigates whether moving R&D from incumbents to startups can increase innovation. Using comprehensive drug development data, we examine the outcomes of drug projects licensed from large firms to startups. We find that these projects licensed to startups...
View Details
Keywords:
Product Development;
Innovation and Invention;
Business Startups;
Research and Development;
Performance Efficiency;
Pharmaceutical Industry
Hammoudeh, Mosab, Joshua Lev Krieger, and Jiajie Xu. "Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency." Harvard Business School Working Paper, No. 24-067, March 2024.
- April 2024
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of...
View Details
Keywords:
Cost vs Benefits;
Decisions;
Judgments;
Values and Beliefs;
Global Strategy;
Health Care and Treatment;
Patents;
Growth and Development Strategy;
Growth Management;
Product Positioning;
Supply and Industry;
Supply Chain;
Corporate Social Responsibility and Impact;
Mission and Purpose;
Philanthropy and Charitable Giving;
Opportunities;
Social Issues;
Equality and Inequality;
Pharmaceutical Industry;
Health Industry;
Denmark;
United States;
Europe;
China;
India;
Middle East;
North Africa
- March 2024
- Case
Teamworks: Tackling a Forecasting Fumble (A)
By: N. Louis Shipley and Stacy Straaberg
In late March 2018, Teamworks CEO Zach Maurides learned Q1 2018 sales were at risk for a large forecasting miss. Founded in 2004, Teamworks’s software application assisted support staff in messaging, scheduling, and sharing documents with collegiate and professional...
View Details
Keywords:
Acquisition;
Business Growth and Maturation;
Communication Strategy;
Decisions;
Forecasting and Prediction;
Business Cycles;
Technological Innovation;
Sports;
Growth and Development Strategy;
Resource Allocation;
Marketing;
Sales;
Business Strategy;
Expansion;
Sports Industry;
Technology Industry;
United States;
North Carolina
- March 2024
- Supplement
Teamworks: Tackling a Forecasting Fumble (B)
By: N. Louis Shipley, Stacy Straaberg and Tom Quinn
In late March 2018, Teamworks CEO Zach Maurides learned Q1 2018 sales were at risk for a large forecasting miss. Founded in 2004, Teamworks’s software application assisted support staff in messaging, scheduling, and sharing documents with collegiate and professional...
View Details
Keywords:
Acquisition;
Business Growth and Maturation;
Communication Strategy;
Decisions;
Forecasting and Prediction;
Business Cycles;
Technological Innovation;
Sports;
Growth and Development Strategy;
Resource Allocation;
Marketing;
Sales;
Business Strategy;
Expansion;
Sports Industry;
Technology Industry;
United States;
North Carolina
- March 2024
- Case
Hippo: Weathering the Storm of the Home Insurance Crisis
By: Lauren Cohen, Grace Headinger and Sophia Pan
Rick McCathron, CEO of Hippo, considered how the firm’s underwriting model could account for the effects of climate change. Along with providing smart home packages, targeting risk-friendly customers, and using data-driven pricing, the Insurtech used technologically...
View Details
Keywords:
Fintech;
Underwriters;
Big Data;
Insurance Companies;
Global Warming;
Business Model Design;
Weather And Climate Change;
Weather Insurance;
Earnings;
Business Model;
Forecasting and Prediction;
Climate Change;
Environmental Sustainability;
Green Technology;
Technological Innovation;
Natural Environment;
Natural Disasters;
Weather;
Business Strategy;
Competitive Advantage;
Business Earnings;
Insurance;
Social Issues;
Insurance Industry;
United States;
California
- 2021
- Working Paper
Quantifying the Value of Iterative Experimentation
By: Iavor I Bojinov and Jialiang Mao
Over the past decade, most technology companies and a growing number of conventional firms have adopted online experimentation (or A/B testing) into their product development process. Initially, A/B testing was deployed as a static procedure in which an experiment was...
View Details
Bojinov, Iavor I., and Jialiang Mao. "Quantifying the Value of Iterative Experimentation." Harvard Business School Working Paper, No. 24-059, March 2024.
- February 2024
- Case
Innovation Strategy at Stanley Black & Decker: Setting the Direction for Growth
By: David L. Ager and Antonio Manuel Oftelie
On July 1, 2022, Don Allan was appointed Chief Executive Officer of Stanley Black & Decker (SBD). Although Allan had been with the firm for 23 years, most recently serving as President and Chief Financial Officer, he recognized that he was stepping into his new role as...
View Details
- February 2024
- Supplement
Seeds of Innovation: GALY's Quest to Cultivate the Future of Agriculture in the Lab
By: George Serafeim
In 2023, Luciano Bueno, CEO and founder of plant cell culture agriculture company GALY, was considering the best path forward for his company as he planned to pitch Series B investors. GALY, founded in 2019, aimed to produce cotton and other crops from cells grown in...
View Details
Keywords:
Business Model;
Green Technology;
Goods and Commodities;
Growth and Development Strategy;
Science-Based Business;
Entrepreneurship;
Plant-Based Agribusiness;
Business Startups;
Decisions;
Technological Innovation;
Production;
Entrepreneurial Finance;
Agriculture and Agribusiness Industry;
Technology Industry;
Boston;
Sao Paulo
Serafeim, George. "Seeds of Innovation: GALY's Quest to Cultivate the Future of Agriculture in the Lab." Harvard Business School Multimedia/Video Supplement 124-705, February 2024.
- 2024
- Working Paper
Principles and Content for Downstream Emissions Disclosures
By: Robert S. Kaplan and Karthik Ramanna
In a previous paper, we proposed the E-liability carbon accounting algorithm for companies to measure and subsequently reduce their own and their suppliers’ emissions. Some investors and stakeholders, however, want companies to also be accountable for downstream...
View Details
Keywords:
Carbon Emissions;
Disclosure;
Carbon Footprint;
Climate Change;
Measurement and Metrics;
Corporate Disclosure;
Environmental Sustainability;
Corporate Social Responsibility and Impact
Kaplan, Robert S., and Karthik Ramanna. "Principles and Content for Downstream Emissions Disclosures." Harvard Business School Working Paper, No. 24-050, January 2024.
- February 2024
- Case
Best Buy Health: Enabling Care at Home
This case explores retailer Best Buy’s decision to enter health care. Best Buy Health aims to enable care at home across three prongs: consumer health, active aging, and virtual care. A key pillar of Best Buy Health's strategy is leveraging the Geek Squad—the company's...
View Details
- February 2024
- Case
Compass Pathways: Pioneering Psychedelic Treatment
By: Tiona Zuzul, Kisha Lashley and Gamze Yucaoglu
This case follows Compass Pathways, a pioneering company developing treatment for depression based on psilocybin, the compound found in ‘magic mushrooms.’ Psilocybin was a federally illegal substance in the U.S., and a “Schedule I” drug, defined as a drug “with no...
View Details
Keywords:
Commercialization;
Corporate Strategy;
Competitive Strategy;
Product Launch;
Health Testing and Trials;
Research and Development;
Laws and Statutes;
Pharmaceutical Industry;
Europe;
United States;
United Kingdom
Zuzul, Tiona, Kisha Lashley, and Gamze Yucaoglu. "Compass Pathways: Pioneering Psychedelic Treatment." Harvard Business School Case 724-412, February 2024.
- February 2024
- Case
More than Optics: Olympus's Vision to Become a Leading Global MedTech Company
By: David J. Collis and Haisley Wert
In August 2022, CEO Yasuo Takeuchi reflected on Olympus Corporation’s recent transformation from being known as a Japanese consumer camera company to becoming a leading global medical technology (MedTech) company. Over the past dozen years, Takeuchi and prior...
View Details
Keywords:
Global Human Resource Management;
Medical Technology;
Corporate Strategy;
Transformation;
Globalization;
Business Model;
Leading Change;
Organizational Structure;
Organizational Change and Adaptation;
Medical Devices and Supplies Industry;
Japan;
United States
Collis, David J., and Haisley Wert. "More than Optics: Olympus's Vision to Become a Leading Global MedTech Company." Harvard Business School Case 724-426, February 2024.
- January 2024
- Case
Runa
By: Paul Gompers and Carla Larangeira
In early 2022, Courtney McColgan, founder and CEO of Runa, a human resources and payroll Software-as-a-Service platform, faced an unexpected tech market downturn. Founded in 2018, Runa catered to small and medium-sized businesses in Mexico, offering an affordable and...
View Details
- January 2024 (Revised March 2024)
- Case
Tesla Motors in 2024--Turbulence Ahead?
By: Felix Oberholzer-Gee and Kate Stoppiello
Over its 20 years in existence, Tesla had become nearly synonymous with electric vehicles, and the company assumed an enviable market position. By 2023, however, Tesla faced intense competition. Traditional carmakers and EV upstarts were expected to introduce close to...
View Details
Keywords:
Competitive Strategy;
Product Positioning;
Competition;
Industry Growth;
Auto Industry;
North America;
Europe;
China;
Australia
Oberholzer-Gee, Felix, and Kate Stoppiello. "Tesla Motors in 2024--Turbulence Ahead?" Harvard Business School Case 724-446, January 2024. (Revised March 2024.)
- 2024
- Working Paper
The Value of Open Source Software
By: Manuel Hoffmann, Frank Nagle and Yanuo Zhou
The value of a non-pecuniary (free) product is inherently difficult to assess. A pervasive
example is open source software (OSS), a global public good that plays a vital role in the economy
and is foundational for most technology we use today. However, it is...
View Details
Hoffmann, Manuel, Frank Nagle, and Yanuo Zhou. "The Value of Open Source Software." Harvard Business School Working Paper, No. 24-038, January 2024.
- January 2024
- Case
Colbún and Chile’s Energy Transition
By: Forest Reinhardt, Jenyfeer Martinez Buitrago and Mariana Cal
In May 2023, Colbún, Chile’s second-largest electricity generator, plans capacity expansions using renewable energy and storage. This strategy supports Chile’s commitment to carbon neutrality (also known as net zero emissions) by 2050. The case delves into the...
View Details
Reinhardt, Forest, Jenyfeer Martinez Buitrago, and Mariana Cal. "Colbún and Chile’s Energy Transition." Harvard Business School Case 724-026, January 2024.
- January 2024
- Case
Pioneer Natural Resources: Enhancing the Capital Return Strategy with Variable Dividends
In February 2021, Scott Sheffield, the CEO of Pioneer Natural Resources (an independent oil and gas company based in Texas), was considering the possibility of enhancing the firm’s capital return strategy by introducing a variable dividend tied to cash flows in...
View Details
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely...
View Details
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- December 2023
- Case
Raízen: Helping to Decarbonize the World?
By: Gunnar Trumbull, Pedro Levindo, Daniel Tong and Rafaella Mazza
Raízen, the world’s largest sugar and ethanol producer, strived to find ways to expand the second-generation ethanol (E2G) market, which it pioneered. The company planned to invest R$24 billion (around $4.6 billion) in 20 production plants, with a total capacity to...
View Details